The BOD has taken several actions since the 2022 CTAD fallout. Removing CM's Chair title is one significant step, along with hiring and promoting senior management. A key move was bringing on Dr. Lopez-Talavera as head of R&D. Notably, he has been featured in every company PR since his hiring, making milestone commitment statements instead of CM. This signals that Dr. Lopez-Talavera is now tasked with leading the team to deliver on these commitments. A review of his LinkedIn profile will provide a few surprises...
Market Data 
Markets 
AI
